The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).EBI
Freie Universit£T Berlin
Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.EBI
University of Ljubljana
Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.EBI
University of Jordan
Phosphinic acid inhibitors of D-alanyl-D-alanine ligase.EBI
Merck Sharp and Dohme Research Laboratories
Structure-activity relationships of novel potent MurF inhibitors.EBI
Abbott Laboratories
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.BDB
University of Virginia At Charlottesville
Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).BDB
Paradigm Pharmaceuticals